Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology

Recruiting now · Not applicable

Conditions studied: Solid Carcinoma

In brief

This is an open label, single-center, non-randomized clinical trial on utilization of microbiome as biomarkers and therapeutics in immuno-oncology. This research consists of two parts: part 1: development of microbiome biomarkers for immuno-oncology part 2: proof-of-concept trial on the fecal microbiota transplantation in patients who are being treated with immunotherapy for advanced solid tumor

Key facts

Study ID

NCT04264975

Run by

Asan Medical Center

People needed

60

Starts

2018-06-04

Expected to finish

2029-12-31

Last updated by the study team

2026-05-22

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Asan Medical Center — Seoul, Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.